FluoroPharma Medical, Inc. FPMI Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 10:05 PM

FluoroPharma Medical, Inc. FPMI Company Overview

Stock Message Board http://investorshangout.com/search?q=FPMI&...mp;yt1=Go!

FluoroPharma Medical, Inc. FPMI Current Price and Quotes
Last Price 0.60
Previous Close 0.60 Open 0.60
Daily Range 0.60 - 0.60 52wk Range 1.19 - 0.51
Volume 3,866 Dividend N/A
Average Vol (3m) 16,662 Yield N/A
FluoroPharma Medical, Inc. FPMI
Company Information

8 Hillside Avenue
Suite 207
Montclair, NJ 07042

Website: http://www.fluoropharma.com
Phone: 973-744-1565
Email: info@fluoropharma.com

FluoroPharma Medical, Inc. FPMI
We are a molecular imaging company headquartered in Montclair, NJ. The Company was founded to engage in the discovery, development and commercialization of proprietary products for the positron emission tomography (PET) market. The Company's initial focus has been on the development of novel cardiovascular imaging agents that can more efficiently and effectively detect and assess acute and chronic forms of coronary artery disease (CAD). Molecular imaging pharmaceuticals are radiopharmaceuticals...

FluoroPharma Medical, Inc. FPMI
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001402785
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2835 - Diagnostic substances
Business Status Development Stage Company a/o Mar 31, 2008
Incorporated In: NV, USA
Year of Inc. 2007
Employees 4 a/o May 03, 2013
Company Officers/Contacts

Johan Spoor President, CEO
Tamara Rhein CFO
Company Directors

Lawrence Atinsky
Peter S. Conti
Joe Pierro
Johan Spoor
Walter Witoshkin
Company Notes

Formerly=Commercial E-Waste Management, Inc. until 6-2011
Service Providers

Auditor/Accountant
Wolf & Company, P.C.
Boston, MA, 02110
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
Cameron Associates
1370 Avenue of the Americas
New York, NY, 10019
United States

FluoroPharma Medical, Inc. FPMI
FPMI Security Details

Share Structure

Market Value1 $14,628,008 a/o Sep 13, 2013
Shares Outstanding 24,380,013 a/o Aug 14, 2013
Float 10,045,387 a/o May 03, 2013
Authorized Shares 200,000,000 a/o Dec 17, 2012
Par Value 0.001
Shareholders

Shareholders of Record 130 a/o Mar 28, 2013
Short Selling Data

Short Interest 45,740 (-19.06%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

VStock Transfer

FluoroPharma Medical, Inc. FPMI Recent News

Jul 29, 2013 FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
Jun 20, 2013 FluoroPharma Medical Announces Internal Review of Currently Acquired Imaging Data From Phase II Study for CardioPET(TM) (FCPHA)

FluoroPharma Medical, Inc. FPMI Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,423 641 45 -
Sales, General and Admin. 2,702 2,590 807 14
Non-Recurring Items - - - -
Other 24 41 41 1
Operating Income (4,150) (3,272) (893) (15)
Income From Continuing Operations

Add'l Income/Expense Items 133 125 (8) -
Earnings Before Interest and Tax (4,017) (3,147) (901) (15)
Interest Expense - 113 53 3
Earnings Before Tax (4,017) (3,260) (954) (18)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,017) (3,260) (954) (18)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,017) (3,260) (954) (18)
Preferred Stock and Other Adjustments (168) (977) - -
Net Income Applicable to Common Shareholders (4,185) (4,238) (954) (18)

FPMI FluoroPharma Medical, Inc. Research DD Guide

FPMI FluoroPharma Medical, Inc. Stock Message Board http://investorshangout.com/search?q=FPMI&...mp;yt0=Go!
FPMI FluoroPharma Medical, Inc. Stock Quote http://www.otcmarkets.com/stock/FPMI/quote
FPMI FluoroPharma Medical, Inc. Stock Chart http://www.otcmarkets.com/stock/FPMI/chart
FPMI FluoroPharma Medical, Inc. Company Info http://www.otcmarkets.com/stock/FPMI/company-info
FPMI FluoroPharma Medical, Inc. Recent News http://www.otcmarkets.com/stock/FPMI/news
FPMI FluoroPharma Medical, Inc. Financials http://www.otcmarkets.com/stock/FPMI/financials
FPMI FluoroPharma Medical, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/FPMI/filings
FPMI FluoroPharma Medical, Inc. Short Sales http://www.otcmarkets.com/stock/FPMI/short-sales
FPMI FluoroPharma Medical, Inc. Insider Disclosure http://www.otcmarkets.com/stock/FPMI/insider-transactions
FPMI FluoroPharma Medical, Inc. Research Reports http://www.otcmarkets.com/stock/FPMI/research
FPMI FluoroPharma Medical, Inc. Summary http://finance.yahoo.com/q?s=FPMI
FPMI FluoroPharma Medical, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=FPMI+Historical+Prices
FPMI FluoroPharma Medical, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=FPMI
FPMI FluoroPharma Medical, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=FPMI+Basic+Chart
FPMI FluoroPharma Medical, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FPMI+Basic+Tech.+Analysis
FPMI FluoroPharma Medical, Inc. Headlines http://finance.yahoo.com/q/h?s=FPMI+Headlines
FPMI FluoroPharma Medical, Inc. Press Releases http://finance.yahoo.com/q/p?s=FPMI+Press+Releases
FPMI FluoroPharma Medical, Inc. Company Profile http://finance.yahoo.com/q/pr?s=FPMI+Profile
FPMI FluoroPharma Medical, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=FPMI+Key+Statistics
FPMI FluoroPharma Medical, Inc. Industry http://finance.yahoo.com/q/in?s=FPMI+Industry
FPMI FluoroPharma Medical, Inc. Major Holders http://finance.yahoo.com/q/mh?s=FPMI+Major+Holders
FPMI FluoroPharma Medical, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=FPMI+Insider+Transactions
FPMI FluoroPharma Medical, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=FPMI+Insider+Roster
FPMI FluoroPharma Medical, Inc. Income Statement http://finance.yahoo.com/q/is?s=FPMI
FPMI FluoroPharma Medical, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=FPMI
FPMI FluoroPharma Medical, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=FPMI+Cash+Flow&annual
FPMI FluoroPharma Medical, Inc. Nasdaq http://www.nasdaq.com/symbol/FPMI
FPMI FluoroPharma Medical, Inc. Market Watch http://www.marketwatch.com/investing/stock/FPMI
FPMI FluoroPharma Medical, Inc. Bloomberg http://www.bloomberg.com/quote/FPMI:US
FPMI FluoroPharma Medical, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=FPMI
FPMI FluoroPharma Medical, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=FPMI
FPMI FluoroPharma Medical, Inc. Barchart http://www.barchart.com/quotes/stocks/FPMI
FPMI FluoroPharma Medical, Inc. OTC Short Report http://otcshortreport.com/index.php?index=FPMI
FPMI FluoroPharma Medical, Inc. Investopedia http://www.investopedia.com/markets/stocks/FPMI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...